Keith T. Flaherty, MD, FAACR
President-Elect: 2025-2026 Flaherty is director of clinical cancer research and the Richard Saltonstall Endowed Chair in Oncology at Mass...
John D. Carpten, PhD, FAACR
Research Interests Genome sciences and cancer molecular genetics with experience in a number of tumor types, including prostate, breast,...
Larry Saltzman, MD
For his exceptional advocacy for NIH funding. Saltzman was diagnosed in 2010 with chronic lymphocytic leukemia, a type of...
AACR Meetings In Person: Irreplaceable Impact
By Christina Leah B. Kline, PhD Participating at the biggest cancer meeting in the world from the comforts of...
Funding the Unconventional: AACR-MPM Oncology Charitable Foundation Transformative Cancer Research Grants
Born through an innovative partnership between the AACR and the UBS Oncology Impact Fund (OIF) managed by MPM Capital,...
How the AACR-Novocure TTFields Research Grant Opens Doors
What inspires you to pursue innovative research focused on Tumor Treating Fields (TTFields)? Since my early studies of biology,...
NCI Director Shares Impact of AACR Grants on Her Research and Career
W. Kimryn Rathmell, MD, PhD, formerly of Vanderbilt University Medical Center, was appointed by President Biden in 2023 as...
Dr. Hani Goodarzi: Making Inroads in Metastasis Research with AACR Grants
What has inspired you to focus on metastasis, especially in colorectal cancer? Metastasis is ultimately the main cause of death in most cancers. It...
Dr. W. Kimryn Rathmell Shares Impact Of AACR-Supported Research Grants On Renal Cell Carcinoma
W. Kimryn Rathmell, MD, PhD, formerly of Vanderbilt University Medical Center, was appointed by President Biden in 2023 as...